Levi & Korsinsky is investigating Galena Biopharma, Inc. (“Galena Biopharma” or the “Company”) (Nasdaq:GALE) for possible breaches of fiduciary duty. The investigation concerns whether a series of statements Galena Biopharma made regarding its business, prospects, and operations were materially false and misleading.
Click here to learn more about the investigation: http://zlk.9nl.com/galena-biopharma or call: 877-363-5972. There is no cost or obligation to you.
On February 14, 2014, Galena acknowledged that it had paid the investor relations firm The DreamTeam Group to promote the Company. The investigation concerns whether these promotional materials were misleading and/or omitted material information, and whether Company insiders took advantage of the positive press to sell significant amounts of shares for substantial profit.
If you own Gale Biopharma stock and wish to obtain additional information about the investigation and your legal rights, please contact Joseph E. Levi, Esq. either via email at email@example.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/galena-biopharma.Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm’s 26 attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV